SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...
Ivonescimab Monotherapy Achieved Statistically Significant & Clinically Meaningful Improvement over Pembrolizumab Monotherapy Head-to-Head in HARMONi-2 Phase III Trial in 1L...
Contacts Investor Relations investorrelations@sidusspace.com Media Inquiries press@sidusspace.com Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a provider of end-to-end precision...
With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market SizeJUPITER, Fla.,...
CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...
CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...
Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative CAMBRIDGE, Mass., Aug. 6, 2024...
MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company...
MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company...
Second rare disease program with RZ358 in Phase 3 developmentFollows successful treatment of multiple patients with tumor hyperinsulinism under the...
-- Second quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $29.1 million ---- Dosed first patients in...
SANDIEGO, CA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of...
BOSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today...
Contacts Press Enquiries Shilpa Narani | shilpa.narani@renew.com Investor Enquiries Nathan Judge, Anunay Shahi, Nitin Vaid | ir@renew.com ReNew Energy Global...
CORAL GABLES, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”), a late-stage biotechnology company addressing...
New orders across multiple customers and products provide increasing evidence of RFI's market opportunity SAN DIEGO, CA / ACCESSWIRE /...
Access to healthcare services, restaurants, bars and coffee shops top the list of trade-offs house hunters are willing to make...
Total investment income increased 18% to $2.1 million for the quarter compared with the second quarter last year driven by...
Announces Participation in Upcoming Investor Conferences SAN JOSE, Calif., Aug. 5, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer...
Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cureInitial clinical site and pediatric patient identified...
JNJ-2113 Phase 3 ICONIC-LEAD and Phase 3 ICONIC-TOTAL clinical trials in moderate-to-severe plaque psoriasis expected to complete the primary endpoint...
Industry veteran with more than 25 years of experience further strengthens Pagaya’s executive leadership team and deepens capital markets, monetization,...
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company,...
Origin caps make recycling easier with “mono-material” containers, can be made with unmodified virgin PET plastic or 100% recycled PET...
Origin caps make recycling easier with “mono-material” containers, can be made with unmodified virgin PET plastic or 100% recycled PET...
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the...
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial...
LONDON and NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
Contacts For Media enquiries: Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs megan.mccrae@organigram.ca For Investor Relations enquiries:...
Contacts Investor Relations Julie Dewey, Chief Investor Relations and Communications Officer JulieDewey@Orthofix.com (209) 613-6945 Media Relations Denise Landry, Vice President,...
New Fragrances Embrace the Most Memorable Moments of Fall with Fragrances Ranging from Lake Mist and Cedarwood to Amber and...
Proposed acquisition represents significant milestone in global expansion strategy and further strengthens Nuvei's presence in LATAM MONTREAL, Aug. 5, 2024...
HOUSTON, Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare...
WOBURN, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the...
Second Quarter 2024 GAAP Revenue of $236 million Second Quarter 2024 GAAP Net Income of $13.8 million Second Quarter 2024...
Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected in fourth quarter of 2024Progressing clinical studies in MDD,...
NICE’s unified incident capture and data analytics solution will help public safety agencies derive valuable insights from AT&T NG9-1-1 Contacts Corporate...
SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: NEOV), NeoVolta Inc., a leader in advanced energy storage solutions, announces...
Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative CAMBRIDGE, Mass., Aug. 6, 2024...
Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical...
